For the first time, a nano version of carboplatin, used in chemotherapy treatment has been developed, wherein unlike the existing molecule, a higher concentration of the drug will attack the cancerous cells and increase the chances of survival of a patient. A group of five Indian researchers and doctors from the Indian Institute of Technology (IIT), Mumbai; LV Prasad Eye Institute, Apollo Hospitals, Hyderabad; and Tata Memorial Hospital, Mumbai; has researched and developed a nano version of an existing cancer drug, carboplatin. This will reach the cancerous cells at a faster pace, reduce toxicity levels of the chemotherapy drug and further increase chances of survival of the patient. Carboplatin is a chemotherapy drug used against some forms of cancer, especially against cancers affecting brain and central nervous system. If this nano drug is proved successful in human trials, this would be the first nano version of a carboplatin drug in the world. Dr Debraj Shome, Facial Cancer...